Advertisement
Screener

EXAGEN INC. (XGN) Expense Breakdown

EXAGEN INC. Expense Breakdown

No Expense Breakdown for XGN on this site yet.

  • 2026-06-30: Reportable $7.72M.
  • 2025-06-30: Reportable $6.81M.

Source checked: the stored Expense Breakdown page for XGN.

Expenses by product

Cost of sales: each quarter (3 month)

Quarter endReportable
2026-06-30$7.72M
2025-06-30$6.81M

Depreciation, Depletion and Amortization: each quarter (3 month)

Quarter endReportable
2026-06-30$235.00K
2025-06-30$270.00K

Income Tax Expense (Benefit): each quarter (3 month)

Quarter endReportable
2026-06-30$0.00
2025-06-30$37.00K

Operating expenses: each quarter (3 month)

Quarter endReportable
2026-06-30$13.94M
2025-06-30$13.03M

Share-based Payment Arrangement, Expense: each quarter (3 month)

Quarter endReportable
2026-06-30$918.00K
2025-06-30$384.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Freenome, Inc. (FRNM)United States$0.143B
BIODESIX INC (BDSX)United States$0.312B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45